Agios Pharmaceuticals News - AGIO

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Agios Pharmaceuticals Inc AGIO NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.22 -0.41% 53.03 54.10 52.39 53.19 53.25 19:59:37
more quote information »

Recent News

Date Time Source Heading
1/12/202016:00GLOBEAgios Announces “Agios 2025” Strategic Vision and Highlights..
12/23/201907:00GLOBEAgios to Present at the 38th Annual J.P. Morgan Healthcare..
12/16/201916:00GLOBEAgios Receives FDA Breakthrough Therapy Designation for..
12/09/201910:00GLOBEAgios Presents Updated Data for Mitapivat from Extension..
12/09/201908:00GLOBEAgios Presents Translational Data to Further Characterize..
12/08/201909:00GLOBEAgios Establishes Proof-of-Concept for Mitapivat in..
12/02/201907:00GLOBEAgios Appoints Bruce Car, Ph.D., as Chief Scientific Officer
11/25/201907:00GLOBEAgios Appoints Jonathan Biller as Chief Legal Officer
11/13/201910:21GLOBEAgios Announces Closing of Public Offering and Full Exercise..
11/08/201917:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/08/201916:57EDGARCurrent Report Filing (8-k)
11/07/201921:17GLOBEAgios Announces Pricing of $256 Million Public Offering of..
11/06/201916:09EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/06/201916:01GLOBEAgios Announces Proposed Offering of Common Stock
11/06/201909:28GLOBEAgios to Present Broad Set of Clinical and Translational..
11/04/201917:10EDGARCurrent Report Filing (8-k)
10/31/201909:16EDGARQuarterly Report (10-q)
10/31/201907:39EDGARCurrent Report Filing (8-k)
10/31/201907:00GLOBEAgios Reports Business Highlights and Third Quarter 2019..
10/28/201907:20EDGARCurrent Report Filing (8-k)
10/27/201911:50GLOBEAgios Presents Data from Single Agent Dose-Escalation Arm of..
10/17/201907:00GLOBEAgios to Webcast Conference Call of Third Quarter 2019..
10/09/201916:20EDGARAmended Statement of Ownership (sc 13g/a)
10/09/201907:00GLOBEAgios to Present Data from AG-270 Phase 1 Dose-Escalation..
9/30/201911:14EDGARCurrent Report Filing (8-k)
9/30/201910:30GLOBEData from Agios’ Phase 3 ClarIDHy Trial of TIBSOVO®..
9/10/201907:00GLOBEAgios to Present Data From the Phase 3 ClarIDHy Study of..
9/04/201917:05EDGARCurrent Report Filing (8-k)
9/04/201917:00GLOBEAgios Announces Publication of Data for Mitapivat from Core..
8/29/201916:05GLOBEAgios to Present at the Citi 14th Annual Biotech Conference..
8/01/201908:57EDGARQuarterly Report (10-q)
8/01/201907:29EDGARCurrent Report Filing (8-k)
8/01/201907:00GLOBEAgios Reports Business Highlights and Second Quarter 2019..
7/18/201907:00GLOBEAgios to Webcast Conference Call of Second Quarter 2019..
7/16/201912:43EDGARConfidential Treatment Order (ct Order)
7/01/201907:00GLOBEAgios Announces Orlando Oliveira Appointed as Senior Vice..
6/14/201916:22EDGARStatement of Changes in Beneficial Ownership (4)
6/13/201916:08EDGARStatement of Changes in Beneficial Ownership (4)
6/10/201913:12GLOBEAgios to Present at the Goldman Sachs Global Healthcare..
6/05/201916:09EDGARCurrent Report Filing (8-k)
6/05/201916:00GLOBEAgios Announces the Planned Retirement of Chief Scientific..
6/03/201916:03EDGARCurrent Report Filing (8-k)
6/03/201908:00GLOBEAgios Presents Updated Data from Phase 1 Studies of TIBSOVO®..
5/31/201916:10EDGARStatement of Changes in Beneficial Ownership (4)
5/31/201916:09EDGARStatement of Changes in Beneficial Ownership (4)
5/31/201916:08EDGARStatement of Changes in Beneficial Ownership (4)
5/31/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
5/31/201916:06EDGARStatement of Changes in Beneficial Ownership (4)
5/31/201916:05EDGARStatement of Changes in Beneficial Ownership (4)
5/31/201916:04EDGARCurrent Report Filing (8-k)
See more news about this stock »

Your Recent History
Agios Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.